DelveInsight Logo
  • About
  • Consulting
    • Asset Prioritization
    • Business Development
    • Competitive Intelligence
    • Licensing Services
    • Merger and Acquisitions
    • Partner Identification
    • Competitive Benchmarking
    • Portfolio Management
    • R&D Analysis
    • Pipeline Assessment
    • Market Assessment
    • Regulatory Analysis
    • Due Diligence
  • Capabilities
    • Market Research
    • Subscription
    • Competitive Intelligence
    • Business Consulting
  • Report Store
  • Insights
    • Blog
    • Events
    • Case-Study
    • Infographics
    • Press Release
    • Newsletter/Whitepaper
  • Login
  • Contact
  • Cart

Duke University

Popular Posts
  • Celiac Disease: The Hidden Epidemic of Gluten SensitivityCeliac Disease: The Hidden Epidemic of Gluten Sensitivity Aug 14, 2020
  • Wuhan Coronavirus: A global emergencyWuhan Coronavirus: A global emergency Jan 31, 2020
  • Nestle to acquire Aimmune Therapeutics; Vir Bio & GSK's COVID-19 monoclonal antibody therapy; AstraZeneca's Farxiga scores goal in Phase III CDK trialNestle to acquire Aimmune Therapeutics; Vir Bio… Sep 1, 2020
  • The epidemic now has a name: COVID-19The epidemic now has a name: COVID-19 Feb 12, 2020
  • Wet Age-Related Macular Degeneration: Unravelling the complex disease with comprehensive R&DWet Age-Related Macular Degeneration: Unravelling… Feb 14, 2020
  • Retinitis Pigmentosa: A complex disease, and the increasing gap between prevalence and diagnosed prevalenceRetinitis Pigmentosa: A complex disease, and the… Mar 23, 2020
Recent Posts
  • Cervical Cancer Market Has A Lot Going On Under The Hood Sep 18, 2020
  • Lilly’s COVID-19 antibody reduces hospitalization rate; Tiny biologic drug to combat COVID-19; Aziyo Biologics files for $57.5 M IPO; BMS exercises option on Obsidian’s CD40L cell therapy Sep 17, 2020
  • How Are Chatbots Improving Healthcare Service Delivery? Sep 16, 2020
  • While AZ resumes its COVID-19 vaccine trial in the UK; Merck and Gilead are busy making sizeable Breast cancer deals Sep 15, 2020
  • Preventing Cervical Cancer Through Screening And HPV Vaccines Sep 14, 2020
Whitepaper/Newsletter
Whitepaper/Newsletter
Categories
  • Anti-coagulants (7)
  • Articles (397)
  • Business Consultant (542)
  • DelveInsight's Drug Report (163)
  • DelveInsight's Indication Pipeline Reports (77)
  • DelveInsight's Oncology based Reports (47)
  • Editor's pick (6)
  • Featured Post (4)
  • Gene Therapy Products (33)
  • Infographics (41)
  • new therapeutic target (5)
  • News (39)
  • Newsletter (3)
  • Notizia (157)
  • Oncology based Indications (12)
  • PD-1 and PD-L1 inhibitors (5)
  • Pharma Consultant (532)
  • pharma consultant (4)
  • Pharma news (25)
  • Pulmonary arterial hypertension (1)
  • Rising of Orphan Drug Development (3)
  • Snippets (150)
  • Specialized Reports (15)
  • The Business Cocktail (143)
  • Uncategorized (54)
  • Venous Thromboembolism (4)
Delveinsight Logo

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

@error('page_id')
  • {{ $message }}
@enderror
@error('form_name')
  • {{ $message }}
@enderror
Subscribe for latest updates
Useful Links
  • Home
  • About Us
  • PharmDelve
  • Careers
  • Privacy Policy
  • Blog
  • Events
  • Newsletter
  • Report Store
  • Competitive Intelligence
  • Sitemap
  • Case Study
  • Press Release
  • Market Research
  • Business Consulting
We accept :
Paypal
Visa
Discover
Mastercard
Call Us
USA:

+1(919)321-6187

India:

+91-11-45689769,

+91-9650213330

Mail Us

[email protected]

Our Location
USA:

304 S. Jones Blvd #2432, Las Vegas NV 89107

India:

Sector-7, Dwarka, New Delhi-110077, India

DelveInsight Business Research LLP  © 2020 Terms & Conditions
↑
Close
Trending Posts
  • Cervical Cancer Market | Cervical Cancer Pipeline

    Cervical Cancer Market Has A Lot Going On Under The Hood

    Articles

  • recent-pharma-happenings-for-eli-lilly-aziyo-biologics-bms

    Lilly’s COVID-19 antibody reduces hospitalization rate; Tiny biologic drug to combat COVID-19; Aziyo Biologics files for $57.5 M IPO; BMS exercises option on Obsidian’s CD40L cell therapy

    Pharma news

  • Chatbots-in-Healthcare-Service-Delivery

    How Are Chatbots Improving Healthcare Service Delivery?

    Snippets

  • AZ corona Vaccine trial | Merck and Gilead Deal

    While AZ resumes its COVID-19 vaccine trial in the UK; Merck and Gilead are busy making sizeable Breast cancer deals

    News

  • Cervical Cancer Screening | HPV Vaccine

    Preventing Cervical Cancer Through Screening And HPV Vaccines

    Articles

  • Acromegaly Pipeline | Acromegaly Companies |Therapies

    What Does The Acromegaly Pipeline Have Up In Its Sleeve?

    Articles

  • recent-pharma-happenings-for-pfizer-biontech-oncoimmune-recursion

    Pfizer-BioNTech COVID-19 vaccine trials; OncoImmune raises $56 M; Recursion Pharma nets $239 M; Breast cancer research updates

    Pharma news

  • Different-Types-of-Alternative-Medicine

    The State of Alternative Medicine In The Healthcare

    Snippets

  • Pharma news for Bayer Verona Cycle Pharma

    Cycle Pharmaceuticals’ USD 25M Debt Financing; Bayer’s Phase IV REPLACE Trial; Verona’s Pilot Study with pMDI Ensifentrine in COVID Patients

    Articles

  • Multiple Myeloma: An Incurable B-cell malignancy and A Vicious Cycle of Relapse

    Multiple Myeloma: An Incurable B-cell malignancy and A Vicious Cycle of Relapse

    Articles

Sections